Business Model

ProtoKinetix is building value through the independent research of laboratories, both university and private, into applications for its AAGP™ molecule.

We recognize that biotechnology advancements are often subject to expensive and time-consuming regulatory processes. Accordingly, as intellectual properties are developed by our customers, the Company is prepared to assist in marketing and licensing.